This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Sparks: Before we ...

Zane was just 15 months old when his parents noticed something wasn’t right. His eyes, legs and belly were very swollen. At first, it seemed like allergies. As soon as the pediatrician saw Zane, he ...

Focal segmental glomerulosclerosis (FSGS) still lacks an FDA-approved therapy, but late-breaking post hoc results from the phase III DUPLEX trial -- presented at the National Kidney Foundation Spring ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Treatment for 72.1% of patients involved in-center ...

Investigators report encouraging results from a small observational study testing the effect of preemptive therapeutic plasma exchange and rituximab in kidney transplant recipients whose primary cause ...

PHILADELPHIA -- Treatment with sparsentan (Filspari) led to no significant differences in estimated glomerular filtration rate (eGFR) slope compared with irbesartan among patients with focal segmental ...

Each 1-unit reduction in log-transformed urinary protein-creatinine ratio in patients with focal segmental glomerulosclerosis is associated with a 77% decreased risk of end-stage kidney disease, a ...

Focal segmental glomerulosclerosis (FSGS) is a rare form of kidney inflammation (glomerulonephritis) in which the glomeruli become increasingly scarred (sclerotic), leading to progressive loss of ...

PERTH, Australia – Melbourne-based Dimerix Ltd.’s stock shot up nearly 20% on the news that its lead compound, DMX-200, met primary and secondary endpoints in a phase IIa trial in patients with rare ...

Please provide your email address to receive an email when new articles are posted on . Researchers identified functionally relevant risk factors for pediatric primary focal segmental ...

(MENAFN- GetNews)The progressive loss of renal function in focal segmental glomerulosclerosis (FSGS) was reduced by half in the DAPA-CKD study… Italy – 7 June, 2021 – Many patients with the rare ...